HeartWare shares recommended on weakness at Canaccord Canaccord recommends buying HearWare on any weakness related to the Q4 pre-announcement. The firm said sales growth was strong on an absolute basis but might not have met high Street expectations. Shares are Buy rated with a $115 price target.
News For HTWR From The Last 14 Days
Check below for free stories on HTWR the last two weeks.